APA

Dijkgraaf E. M., Santegoets S. J. A. M., Reyners A. K. L., Goedemans R., Wouters M. C. A., Kenter G. G., van Erkel A. R., van Poelgeest M. I. E., Nijman H. W., van der Hoeven J. J. M., Welters M. J. P., van der Burg S. H. & Kroep J. R. (20160707). A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Dijkgraaf E M, Santegoets S J A M, Reyners A K L, Goedemans R, Wouters M C A, Kenter G G, van Erkel A R, van Poelgeest M I E, Nijman H W, van der Hoeven J J M, Welters M J P, van der Burg S H and Kroep J R. 20160707. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Dijkgraaf E. M., Santegoets S. J. A. M., Reyners A. K. L., Goedemans R., Wouters M. C. A., Kenter G. G., van Erkel A. R., van Poelgeest M. I. E., Nijman H. W., van der Hoeven J. J. M., Welters M. J. P., van der Burg S. H. and Kroep J. R. (20160707). A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Dijkgraaf E M, Santegoets S J A M, Reyners A K L, Goedemans R, Wouters M C A, Kenter G G, van Erkel A R, van Poelgeest M I E, Nijman H W, van der Hoeven J J M, Welters M J P, van der Burg S H and Kroep J R. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer. : Annals of oncology : official journal of the European Society for Medical Oncology. 20160707.